Clinical Trial: Cemiplimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
Study Status: Completed
Recruit Status: RECRUITING
Condition: Locally Advanced Basal Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: Neoadjuvant REGN2810 (Cemiplimab) in Cutaneous Basal Cell Carcinoma of the Head and Neck
Brief Summary:
This phase II trial tests how well cemiplimab works in treating basal cell carcinoma of the head and neck that has spread to nearby tissue or lymph nodes (locally advanced) before surgery (neoadjuvant).Cemiplimab is a human recombinant monoclonal IgG4 antibody that may allow the body's immune system to work against tumor cells.Giving cemiplimab before surgery may make the tumor smaller and make it easier to remove.
Read more